carvodil, daksh diabtetic cardiac, daksh pharma panchkula, dakshpharmaceuticals panchckula, pcd franchise, diabetic pcd franchise
Carvedilol, Carvedilol 6.25 mg, Carvedilol, Carvodil-6.25, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product
carvodil, daksh diabtetic cardiac, daksh pharma panchkula, dakshpharmaceuticals panchckula, pcd franchise, diabetic pcd franchise
Carvedilol, Carvedilol 6.25 mg, Carvedilol, Carvodil-6.25, daksh, daksh diabetic and cardiac, daksh pharma panchkula, daksh diabetic and cardiac panchkula, pcd franchise, pcd franchise company in panchkula, daksh group, pharma companies, pharma products, franchise, speciality product

CARVODIL-6.25

Tab Carvodil-6.25 (Carvedilol 6.25 mg ) ALU-ALU 10 X 10
Category: Tag:
Send Enquiry
Introduction:

CARVODIL-6.25 is a beta-blocker formulation containing Carvedilol 6.25 mg, widely prescribed for the treatment of hypertension, heart failure, and post-myocardial infarction. By blocking alpha and beta-adrenergic receptors, Carvedilol reduces cardiac workload, improves heart function, and lowers blood pressure.

With its dual-action mechanism, CARVODIL-6.25 improves survival rates in heart failure patients and reduces the risk of recurrent cardiac events. Packaged in ALU-ALU strips (10 x 10 tablets), it offers reliable dosing with long-lasting shelf stability.

Product Composition & Packaging:
  • Composition: Carvedilol 6.25 mg
  • Packaging: ALU-ALU, 10 x 10 Tablets
  • Form: Oral tablet
Indications for CARVODIL-6.25
  • Mild to moderate hypertension
  • Chronic heart failure (NYHA Class II & III)
  • Post-myocardial infarction with left ventricular dysfunction
  • Stable angina pectoris
  • Adjunct therapy in patients with coronary artery disease
Dosage and Administration:
  • Initial dose: One tablet (6.25 mg) twice daily
  • Maintenance dose: Adjust as needed under medical supervision; may increase gradually based on tolerance and response
  • Administer with food to reduce the risk of orthostatic hypotension

Important: Dosage should always be individualized and adjusted by a physician, especially in heart failure patients.

Precautions & Warnings:
  • Use cautiously in patients with bronchospastic disorders, bradycardia, or liver dysfunction
  • Monitor blood pressure, heart rate, and blood glucose levels in diabetic patients
  • Taper dosage gradually before discontinuation to avoid rebound hypertension or arrhythmias
  • Contraindicated in severe hepatic impairment, second/third-degree heart block, or cardiogenic shock
  • Not recommended during pregnancy or lactation
Possible Side Effects:
  • Dizziness or fatigue, especially during dose titration
  • Bradycardia (slow heart rate)
  • Hypotension or postural light-headedness
  • Gastrointestinal discomfort, diarrhea
  • In rare cases, worsening of heart failure symptoms
Conclusion:

CARVODIL-6.25 is a proven therapeutic solution for managing hypertension, heart failure, and post-MI recovery. Its balanced alpha and beta-blocking action helps reduce the heart’s workload while protecting against further cardiac damage. Designed for long-term cardiovascular safety, it is ideal for patients requiring steady control over blood pressure and heart function.

If you’re looking to buy Carvedilol tablets online, choose CARVODIL-6.25 for clinically effective treatment, patient comfort, and high manufacturing standards in every dose.

Note : Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.

For more such product information and similar product category Cardiac

You can also contact us  https://diabetes-cardiac.com/contact-us/

Related products